Placental function evaluation focusing on placental blood flow and oxygenation by imaging, mainly non-contrasted placental MRI in pregnant women

Placental function evaluation focusing on placental blood flow and oxygenation by imaging, mainly non-contrasted placental MRI in pregnant women - Evaluation of placental function by non-contrast enhanced MRI in pregnant women

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039543

Enrollment

Registered

2020-02-20

Start date

2017-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Growth Restriction

Interventions

Non-contrast-enhanced MRI is performed in the second trimester (20 to 28 weeks) and late (29 to 37 weeks).

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1)Pregnant women who do not judge that the doctor is incompatible 1.The umbilical cord attachment is lateral 2.The umbilical cord attachment is marginal 3.The mother has pregnancy-induced hypertension syndrome 4.The mother has gestational diabetes 5.Unknown cause of fetal growth restriction (2) Pregnancy 20 weeks or more and less than 37 weeks (3) For pregnant women, the expected delivery date is determined according to the Gynecology and Obstetrics Practice Guidelines-Obstetrics Edition 2014. (4) Informed consent has been obtained from the person (maternal) regarding participation in the test

Exclusion criteria

Exclusion criteria: Patients who are judged inappropriate by the Principal Investigator or Research Investigator as study subjects.

Design outcomes

Primary

Measure	Time frame
Maximum BOLD value during shooting period	—

Countries

Japan

Contacts

Public Contactmasafumi nii

Mie University Hospital Obstetrics and gynecology

tadafer.study@gmail.com059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026